Literature DB >> 29204800

Hospital pharmacists' perceived beliefs and responsibilities in indication-based off-label prescribing.

Ramsankar Basak1, David J McCaffrey2.   

Abstract

Background Off-label prescribing is prevalent in healthcare. There is a lack of understanding of pharmacists' attitudes toward the practice of off-label prescribing, especially those that are prescribed for other indications than approved ones (termed as indication-based off-label prescribing). Objective Explore hospital pharmacists' attitudes toward and perceived responsibility in off-label and indication-based off-label prescribing in hospital pharmacy practice. Setting Pharmacists practicing in hospitals in the United States were investigated. Method Pharmacists were contacted via email through State affiliates of the American Society of Health-System Pharmacist. The survey described an indication-based off-label medication order for a hospitalized patient and the prescribing physician. Data were collected via Qualtrics. Main outcome measure Questions focused on awareness, beliefs, and responsibility-including, risk assessment and monitoring outcomes-related to off-label and indication-based offlabel prescribing. Results Of 107 pharmacist respondents, about 79% and 98% reported being familiar with offlabel and indication-based off-label prescribing, respectively. While 77.6% pharmacists believed that patients should be informed, only 37.4% agreed that they had responsibility of informing physicians; presence of policy was associated (p < 0.02) with pharmacist agreeing to inform physicians. Over 70% agreed that patients should be closely monitored for outcomes and 43.1% believed physicians had predominant responsibility of monitoring outcomes. Conclusion Pharmacists' perceived responsibility and beliefs regarding off-label prescribing are insightful that can be utilized for improving patient care.

Entities:  

Keywords:  Attitudes; Hospital pharmacists; Off-label prescribing; Pharmacy practice; Responsibility; United States

Mesh:

Year:  2017        PMID: 29204800     DOI: 10.1007/s11096-017-0567-7

Source DB:  PubMed          Journal:  Int J Clin Pharm


  19 in total

1.  Off-label use of drugs in Italy: a prospective, observational and multicentre study.

Authors:  C Pandolfini; P Impicciatore; D Provasi; F Rocchi; R Campi; M Bonati
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

2.  Unlicensed and off-label drug use in children: implications for safety.

Authors:  Imti Choonara
Journal:  Expert Opin Drug Saf       Date:  2004-03       Impact factor: 4.250

3.  United States medical practice summary: innovative off-label medication use.

Authors:  Nicole Ansani; Robert Branch; Bethany Fedutes-Henderson; Thomas Smitherman; Robert J Weber; Susan Skledar; Nathalie Zgheib; Carl Sirio
Journal:  Am J Med Qual       Date:  2006 Jul-Aug       Impact factor: 1.852

4.  Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.

Authors:  Derek Stewart; Abdul Rouf; Ailsa Snaith; Kathleen Elliott; Peter J Helms; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

5.  Off-label prescribing to children: attitudes and experience of general practitioners.

Authors:  Suzie Ekins-Daukes; Peter J Helms; Michael W Taylor; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

6.  Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.

Authors:  Tareq Mukattash; Ahmed F Hawwa; Karen Trew; James C McElnay
Journal:  Eur J Clin Pharmacol       Date:  2011-01-18       Impact factor: 2.953

7.  Defining off-label and unlicensed use of medicines for children: results of a Delphi survey.

Authors:  Antje Neubert; Ian C K Wong; Alessandro Bonifazi; Mariana Catapano; Mariagrazia Felisi; Paola Baiardi; Carlo Giaquinto; Catherijne A J Knibbe; Miriam C J M Sturkenboom; Maisoon A Ghaleb; Adriana Ceci
Journal:  Pharmacol Res       Date:  2008-09-18       Impact factor: 7.658

8.  A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.

Authors:  John Sellors; Janusz Kaczorowski; Connie Sellors; Lisa Dolovich; Christel Woodward; Andrew Willan; Ron Goeree; Roxanne Cosby; Kristina Trim; Rolf Sebaldt; Michelle Howard; Linda Hardcastle; Jeff Poston
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

9.  Off-label drug use among hospitalised children: identifying areas with the highest need for research.

Authors:  Linda Hsien; André Breddemann; Anne-Kristina Frobel; Andreas Heusch; Klaus G Schmidt; Stephanie Läer
Journal:  Pharm World Sci       Date:  2008-01-26

10.  Public awareness and views on unlicensed use of medicines in children.

Authors:  T L Mukattash; J S Millership; P S Collier; J C McElnay
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

View more
  1 in total

1.  Assessment of Knowledge, Attitude, and Practice of Obstetricians and Gynecologists Toward Off-Label Medicine Use in Female Reproductive Health Issues.

Authors:  Sadia Shakeel; Wajiha Iffat; Ambreen Qamar; Shagufta Nesar; Fareeha Butt; Sobia Naseem Siddiqui; Hina Rehman; Anees Ur Rehman
Journal:  Front Public Health       Date:  2022-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.